Home / Indicator library / Biotechnology and Medical Care / Unicocell (6794) overview
Unicocell (6794) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for Unicocell, on one page
中文版 (Chinese)
Unicocell (6794) snapshot, key figures
Revenue YoY (2026-06)
-43.0%
Monthly revenue (2026-06)
TWD 0.00bn
Sector
Biotechnology and Medical Care
Listing venue
Taiwan Stock Exchange
Values above are the official-source snapshot for Unicocell (6794) on 2026-08-04. We do not chase live quotes. Every trading day is frozen as its own point-in-time vintage, so a backtest reading this data sees only what was actually knowable that day, with no look-ahead bias. Missing values stay blank. Nothing is interpolated or extrapolated.
Unicocell (6794): where today sits in the past year
Current value against the 2025-08-04 to 2026-08-04 range, built from 243 frozen daily vintages.
Price / book5.72x9th percentile of the past year
5.42xmedian 6.14x7.69x
The marker is today's value; the faint tick is the one-year median. Every point in this range is the number as it was published on its own date, never a restated figure, so the percentile is what a reader on that day could actually have computed. Ratios at or below zero are excluded rather than treated as cheap. Tickers with fewer than 60 observed dates get no range at all.
That is this ticker against its own past. The other axis — where the same readings sit across the whole market on the same day — is
directly below; the two can point in different directions, so both are worth reading. The full decile structure lives on the
market P/E,
P/B and
dividend yield pages.
Unicocell (6794): where today sits across the whole market
The same figures read against every other listed company on 2026-08-04, rather than against this ticker's own history.
Price / book5.72x92nd percentile market-wide
10th pct0.71xmarket median1.62x90th pct5.05x
Valid sample per metric: price / book 1,082. The three metrics are sampled independently rather than intersected, so the denominators differ — an intersection would turn every percentile into the percentile of whichever companies happen to disclose all three, a population nobody is asking about. Ratios at or below zero are excluded rather than counted as cheap; a zero dividend yield is kept because paying nothing is a real observation. The bar spans the 10th to 90th percentile, not the full range, because a handful of four-digit multiples would otherwise flatten every other company into the left edge; the percentile itself is computed on the full population and is unaffected.
Loading checkup signals…
Seven-dimension checkup for this ticker →
6794: common questions
What is 6794's price-to-book ratio?
6794's price-to-book ratio was 5.72x on 2026-08-04, taken as-is from the official public source.
How fast is 6794's revenue growing?
6794 reported -43.0% year-on-year monthly revenue growth for 2026-06, from the official monthly revenue filing.
Is 6794's price / book high or low right now?
6794's price / book is 5.72x, which is below its one-year median of 6.14x and sits at the 9th percentile of the 5.42–7.69x range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
How does 6794's price / book compare with the rest of the Taiwan market?
6794's price / book of 5.72x is above the market median of 1.62x and sits at the 92nd percentile of the 1,082 tickers carrying a valid reading that day — 89 of them read higher. This is the cross-section on a single frozen date, a different question from where the ticker sits against its own past year.
Everything on this page is either the official public source shown as-is, or a transparent derivation you can reproduce. The free tier covers 2330 in full as a reference case; on other tickers some blocks are paid-tier. What we sell is data and tooling, not investment advice, not stock tips, and not a promise of returns.